Ardelyx, Inc.
ARDX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001437402
In the last 90 days, Ardelyx, Inc. insiders filed 0 open-market purchases and 9 sales; 250 institutions reported holding it in 13F filings for Q2 2026, worth $906.4M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Ardelyx, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 104
- +22 vs. Q3 2022
- Shares held
- 80.4M
- +13.5M (+20.3%) vs. Q3 2022
- Total value
- $225.7M
- +$146.1M (+183.6%) vs. Q3 2022
- New holders
- 40
- 32 more added
- Sold out
- 18
- 19 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 250 | $906.4M |
| Q1 2026 | 242 | $1.01B |
| Q4 2025 | 229 | $972.9M |
| Q3 2025 | 223 | $891.4M |
| Q2 2025 | 206 | $657.3M |
| Q1 2025 | 221 | $808.7M |
| Q4 2024 | 213 | $765.2M |
| Q3 2024 | 203 | $982.8M |
| Q2 2024 | 197 | $1.07B |
| Q1 2024 | 189 | $1.03B |
| Q4 2023 | 161 | $849.0M |
| Q3 2023 | 150 | $513.5M |
| Q2 2023 | 146 | $426.0M |
| Q1 2023 | 130 | $550.1M |
| Q4 2022 | 104 | $225.7M |
| Q3 2022 | 83 | $79.6M |
| Q2 2022 | 78 | $22.7M |
| Q1 2022 | 89 | $42.4M |
| Q4 2021 | 100 | $46.0M |
| Q3 2021 | 108 | $66.7M |
| Q2 2021 | 127 | $643.2M |
| Q1 2021 | 125 | $559.7M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Ardelyx, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Woodline Partners LP | 3,475,960 | $9.91M | 0.14% | −1,863,105−34.9% | Reduced |
| Vanguard Group Inc | 8,313,513 | $23.7M | 0.00% | +2,567,995+44.7% | Added |
| Millennium Management LLC | 10,383,329 | $29.6M | 0.03% | +9,435,291+995.2% | Added |
| Janus Henderson Group PLC | 19,774,333 | $56.1M | 0.04% | +11,520,955+139.6% | Added |
| Deep Track Capital, LP | 0 | $0 | 0.00% | −14,858,000−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −1,852,081−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −1,573,325−100.0% | Sold out |
| AIGH Capital Management LLC | 0 | $0 | 0.00% | −1,487,476−100.0% | Sold out |
| Prosight Management, LP | 0 | $0 | 0.00% | −1,126,127−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −798,405−100.0% | Sold out |
| Worth Venture Partners, LLC | 0 | $0 | 0.00% | −364,102−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −336,018−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −226,221−100.0% | Sold out |
| Donaldson Capital Management, LLC | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| New York Life Investments Alternatives | 0 | $0 | 0.00% | −79,142−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −75,417−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −45,956−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −13,531−100.0% | Sold out |
| Waller Financial Planning Group, Inc | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Westhampton Capital, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −2,883−100.0% | Sold out |
| Pinz Capital Management, LP | – | – | – | – | Not filed |